688526.SH
科前生物
SSE · Healthcare · Biotechnology · CN
CNY 12.97
−0.92%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
10.2x
EV/EBITDA
9.7x
Market Cap
CNY 6.05B
MomentumView details →
1D Return
−0.92%
YTD Return
—
RSI (14)
47.8
ValuationView details →
P/E (Fwd)
10.2x
EV/EBITDA
9.7x
Market Cap
CNY 6.05B
RSI (14)
47.8
MomentumView details →
1D Return
−0.92%
YTD Return
—
Similar companies
Latest newsMore news →
Keqian Biology announced its first-half 2026 results: net profit attributable to shareholders was 116 million yuan, down 47.37% year-on-year.9d agoKeqian Biology received approval from the Ministry of Agriculture and Rural Affairs of the People's Republic of China for its avian adenovirus (group I, type 4) inactivated vaccine (HB-2 strain) to be registered as a new veterinary drug, and obtained the new veterinary drug registration certificate.12d ago